SMT201900345T1 - Uso di palmitoiletanolamide in combinazione con oppiodi - Google Patents

Uso di palmitoiletanolamide in combinazione con oppiodi

Info

Publication number
SMT201900345T1
SMT201900345T1 SM20190345T SMT201900345T SMT201900345T1 SM T201900345 T1 SMT201900345 T1 SM T201900345T1 SM 20190345 T SM20190345 T SM 20190345T SM T201900345 T SMT201900345 T SM T201900345T SM T201900345 T1 SMT201900345 T1 SM T201900345T1
Authority
SM
San Marino
Prior art keywords
palmitoylethanolamide
opioids
combination
Prior art date
Application number
SM20190345T
Other languages
English (en)
Italian (it)
Inventor
Valle Francesco Della
Valle Maria Federica Della
Cesare Manelli Lorenzo Di
Carla Ghelardini
Original Assignee
Epitech Group S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epitech Group S P A filed Critical Epitech Group S P A
Publication of SMT201900345T1 publication Critical patent/SMT201900345T1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dispersion Chemistry (AREA)
SM20190345T 2014-05-14 2015-05-04 Uso di palmitoiletanolamide in combinazione con oppiodi SMT201900345T1 (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20140876 2014-05-14
EP15166284.8A EP2944309B1 (en) 2014-05-14 2015-05-04 Use of palmitoylethanolamide in combination with opioids

Publications (1)

Publication Number Publication Date
SMT201900345T1 true SMT201900345T1 (it) 2019-07-11

Family

ID=51179022

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20190345T SMT201900345T1 (it) 2014-05-14 2015-05-04 Uso di palmitoiletanolamide in combinazione con oppiodi

Country Status (17)

Country Link
US (1) US9801836B2 (enExample)
EP (1) EP2944309B1 (enExample)
JP (1) JP6563685B2 (enExample)
KR (1) KR102507891B1 (enExample)
CN (1) CN105079811B (enExample)
AR (1) AR100444A1 (enExample)
AU (1) AU2015202575B9 (enExample)
BR (1) BR102015011079A2 (enExample)
CA (1) CA2891049C (enExample)
CY (1) CY1121773T1 (enExample)
DK (1) DK2944309T3 (enExample)
ES (1) ES2731729T3 (enExample)
HU (1) HUE044915T2 (enExample)
PL (1) PL2944309T3 (enExample)
PT (1) PT2944309T (enExample)
SM (1) SMT201900345T1 (enExample)
TR (1) TR201908936T4 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7244992B2 (ja) * 2015-05-21 2023-03-23 エスシーアイ スパーク リミティド オピオイドとn-アシルエタノールアミンの組み合わせ
SG10201802129QA (en) 2017-07-05 2019-02-27 Frimline Private Ltd A pharmaceutical composition for neuropathic pain
PH12018000227B1 (en) 2017-09-05 2019-03-11 Frimline Private Ltd A pharmaceutical composition for improving or preventing progression of chronic kidney disease
WO2020141546A1 (en) * 2019-01-02 2020-07-09 Celagenex Research (India) Pvt. Ltd. Synergistic nutritional compositions for pain management
EP4681710A1 (en) * 2024-07-18 2026-01-21 EPITECH GROUP S.p.A. 2-pentadecyl-2-oxazoline as an opioid adjuvant to prevent or treat hyperalgesia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271266B (it) 1994-12-14 1997-05-27 Valle Francesco Della Impiego terapeutico di ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi
WO2001010434A1 (en) 1999-08-06 2001-02-15 Innovet Italia S.R.L. Pharmaceutical compositions containing n-palmitoylethanolamide and use thereof in the veterinary field
DE60228713D1 (de) 2001-07-18 2008-10-16 Unilever Nv Zusammensetzungen für die behandlung von haaren und/oder kopfhaut
US20050245557A1 (en) * 2003-10-15 2005-11-03 Pain Therapeutics, Inc. Methods and materials useful for the treatment of arthritic conditions, inflammation associated with a chronic condition or chronic pain
CA2756178A1 (en) * 2009-03-27 2010-09-30 Abbott Laboratories Compounds as cannabinoid receptor ligands
ES2548190T3 (es) * 2009-09-07 2015-10-14 Epitech Group S.P.A. Composición que contiene palmitoiletanolamida ultramicronizada

Also Published As

Publication number Publication date
BR102015011079A2 (pt) 2016-03-29
KR20150130931A (ko) 2015-11-24
JP6563685B2 (ja) 2019-08-21
PT2944309T (pt) 2019-06-05
ES2731729T3 (es) 2019-11-18
HUE044915T2 (hu) 2019-11-28
AR100444A1 (es) 2016-10-05
JP2015221794A (ja) 2015-12-10
EP2944309A1 (en) 2015-11-18
KR102507891B1 (ko) 2023-03-08
US9801836B2 (en) 2017-10-31
CN105079811B (zh) 2020-06-23
AU2015202575A1 (en) 2015-12-03
AU2015202575B2 (en) 2020-03-05
CA2891049A1 (en) 2015-11-14
US20150328173A1 (en) 2015-11-19
CA2891049C (en) 2023-02-21
CY1121773T1 (el) 2020-07-31
CN105079811A (zh) 2015-11-25
TR201908936T4 (tr) 2019-07-22
DK2944309T3 (da) 2019-06-03
AU2015202575B9 (en) 2020-03-26
PL2944309T3 (pl) 2019-09-30
EP2944309B1 (en) 2019-03-20

Similar Documents

Publication Publication Date Title
IL248970A0 (en) Pyrazolopyridine and pyrazolopyrimidine type substances and their uses
IL252216A0 (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
GB201411197D0 (en) Composition and use thereof
ZA201605639B (en) Hppd variants and methods of use
PT3015526T (pt) Composição à base de hidrofluoroolefina e sua utilização
PT3480213T (pt) Polipéptidos syntac e utilizações dos mesmos
IL251064A0 (en) Peptidomimetic macrocycles and their uses
GB201401617D0 (en) Novel combination and use
PL3194656T3 (pl) Uchwyt listwy uszczelniającej oraz jego zastosowanie
ZA201606243B (en) Hppd variants and methods of use
GB201417048D0 (en) Occupancy-control device and methods of use
SI3233105T1 (sl) Nove kombinacije in uporaba
GB201512044D0 (en) Application in German
IL251335A0 (en) Piperidinylpyrazolopyrimidinones and their use
IL248424B (en) Neuroprotective substances and their uses
GB201411196D0 (en) Composition and use thereof
PL2944309T3 (pl) Zastosowanie palmitoiloetanoloamidu w połączeniu z opioidami
LT3215143T (lt) Derinys, apimantis spiruliną ir palmitoiletanolamidą
GB201408091D0 (en) Methods and uses
PL3229772T3 (pl) 6-arylo-9-glikozylopuryny i ich zastosowanie
GB2530075B (en) Improvements in and relating to eyewashing
GB201404831D0 (en) Animalistic studies in nature
GB201404728D0 (en) Disc-over incorporating disc-heads and disc-earning
GB201416086D0 (en) Methods and uses
GB201416073D0 (en) Methods and uses